From: Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
Parameters
Number (%)
iPSA
< 10
18 (47%)
10–20
16 (42%)
> 20
4 (11%)
Stage
T1c
6 (16%)
T2a
10 (26%)
T2c
T3a
T4
2 (6%)
Gleason score
< or = 5
6–7
25 (66%)
8–10
11 (28%)
HT
No
7 (18%)
Yes
31 (82%)